Dendritic cell-based immunotherapy is the administration of individually manufactured vaccines based on the genetic characteristics of a tumor in a particular person. Cancer treatment with dendritic cells is indicated even for those patients who have not responded to all other types of therapy. In Europe, vaccination is possible in any stage of cancer and has virtually no contraindications.
Lung cancer is the most common group of malignant tumors in the world, which develops from cells in the lungs and bronchi. It develops 10% more often in men than in women. Today, Germany can offer new treatment methods, which allow for achieving excellent results even at stage 4 of the pathology. The patients' life quality can be improved, and their life expectancy can be increased as well.
Stem cell usage is one of the most perspective medical fields. In Germany and other developed countries, huge amounts of money are invested in the research and development of this field, since in the future, it will allow the curing of many diseases which are still incurable. However, not many people are interested in the future.
A lung cancer vaccine is a modern opportunity to achieve cancer remission at any stage and reduce the risk of disease recurrence. Clinics in Germany carry out dendritic cell vaccination in parallel with surgical treatment, radiation therapy, and chemotherapy. In the manufacture of the vaccine, German doctors use fragments of...
Immunotherapy is an innovative method of cancer treatment. With immunotherapy, physicians interfere in the interaction of the patient's immune system and a malignant tumor. Immunotherapy can be successfully combined with classical methods of treatment, and German oncologists make it individualized — drugs are selected...
Immunotherapy is one of the most effective treatment options for lymphoma. It is used in combination with chemotherapy and has also become a life-saving treatment for many patients whose tumor has recurred and chemotherapy is no longer working. Some types of immunotherapy are so effective that they can even cure aggressive end-stage lymphomas.
Over 400,000 new cases of bladder cancer are diagnosed in the world annually. In 75% of patients, the tumor is detected at an early stage. However, in every fourth person it is detected when it is at the stage of invasive bladder cancer, after lymph node lesions are present, or after the appearance of distant metastases.
Regenerative cell medicine uses stem cells (SCs) to repair damaged bone marrow, nerve tissue, the musculoskeletal system, or to generally rejuvenate a person. With careful harvesting and processing in laboratory conditions, SCs can become the source of most types of differentiated cells in an adult organism. The leading clinics...